Register to MarketScale.com for Jose Medina-Inojosa episodes, events, and more.
Recent Posts

Revolutionary Advancements in Hypertension Treatment: Zilebesiran Redefines the Landscape
Jose Medina-Inojosa - July 25, 2023Assistant Professor of Epidemiology for the Mayo Clinic College of Medicine at Mayo Clinic, Jose Medina-Inojosa MD MSc, breaks down the groundbreaking innovation in hypertension treatment with the introduction of Zilebesiran. Published in the prestigious New England Journal of Medicine, this study has ignited excitement in the medical community, offering new hope for the millions affected by hypertension, the notorious "silent killer.
Read more
Next Steps in Hypertension Management
Jose Medina-Inojosa - November 30, 2022We tested the hypothesis that BF content measured by air displacement plethysmography (Bod-Pod®) had a stronger association with prevalent hypertension (HTN), diabetes mellitus (DM) and dyslipidemia (DLP) when compared to BMI.
Read more
Association Between Arrhythmia Burden During Clinical Exercise Testing and All-Cause Mortality
Jose Medina-Inojosa - November 30, 2022Arrhythmias commonly occur during clinical exercise stress testing (EST), however there are limited data on prognostic significance, particularly differences between individuals with minor versus significant arrhythmia burden. We hypothesized that significant but not minor arrhythmia burden during EST would be predictive of future all-cause mortality.
Read more
Mayo Clinic Doctor Says Mark Cuban’s Cost Plus Drugs is Bringing “Access” to U.S. Healthcare
Jose Medina-Inojosa - November 11, 2022Mark Cuban's Cost Plus Drugs is making waves in the pharmacy market, gaining more than 1.2 million customers and selling over 1000 generic low-cost drugs at a fraction of the prescription price that Big Pharma puts on the marketplace.
Read more
Innovative Insights Into Subclinical Cardiovascular Disease: coronary artery calcification and beyond
Jose Medina-Inojosa - October 30, 2022We have previously shown that ECG-derived age (ECG-Age) predicts all-cause and cardiovascular (CV) mortality, reflecting physiologic age. We hypothesized that ECG-Age minus chronological age (Age-Gap) would be associated with coronary artery calcium (CAC) assessed by computer tomography.
Read more
A look into the future of exercise and cardiopulmonary fitness
Jose Medina-Inojosa - October 30, 2022The physiological changes associated with aging have deleterious effects on cardiovascular function. In addition, increasing evidence showed the effect of exercise on improving cardiovascular health and reducing the aging process. The present study sought to demonstrate the association between exercise and biological age, estimated by our previously reported method using artificial intelligence-enabled electrocardiography (ECG).
Read more